Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
07 2020
Historique:
received: 15 01 2020
revised: 14 03 2020
accepted: 31 03 2020
pubmed: 8 4 2020
medline: 20 11 2021
entrez: 8 4 2020
Statut: ppublish

Résumé

Glioblastoma (GBM), an incurable tumor, remains difficult to model and more importantly to treat due to its genetic/epigenetic heterogeneity and plasticity across cellular states. The ability of current tumor models to recapitulate the cellular states found in primary tumors remains unexplored. To address this issue, we compared single-cell RNA sequencing of tumor cells from 5 patients across four patient-specific glioblastoma stem cell (GSC)-derived model types, including glioma spheres, tumor organoids, glioblastoma cerebral organoids (GLICO), and patient-derived xenografts. We find that GSCs within the GLICO model are enriched for a neural progenitor-like cell subpopulation and recapitulate the cellular states and their plasticity found in the corresponding primary parental tumors. These data demonstrate how the contribution of a neuroanatomically accurate human microenvironment is critical and sufficient for recapitulating the cellular states found in human primary GBMs, a principle that may likely apply to other tumor models. SIGNIFICANCE: It has been unclear how well different patient-derived GBM models are able to recreate the full heterogeneity of primary tumors. Here, we provide a complete transcriptomic characterization of the major model types. We show that the microenvironment is crucial for recapitulating GSC cellular states, highlighting the importance of tumor-host cell interactions.

Identifiants

pubmed: 32253265
pii: 2159-8290.CD-20-0057
doi: 10.1158/2159-8290.CD-20-0057
pmc: PMC10256258
mid: NIHMS1582584
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

964-979

Subventions

Organisme : NCI NIH HHS
ID : DP1 CA228040
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM083937
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2020 American Association for Cancer Research.

Références

Cell Stem Cell. 2020 Jan 2;26(1):48-63.e6
pubmed: 31901251
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Cancer Cell. 2006 May;9(5):391-403
pubmed: 16697959
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Science. 2017 Mar 31;355(6332):
pubmed: 28360267
Cell Rep. 2017 Oct 31;21(5):1399-1410
pubmed: 29091775
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Cell. 2014 Apr 24;157(3):580-94
pubmed: 24726434
Stem Cells. 2010 Jan;28(1):5-16
pubmed: 19904829
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Cancer Res. 2016 Apr 15;76(8):2465-77
pubmed: 26896279
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Cancer Discov. 2019 Dec;9(12):1708-1719
pubmed: 31554641
Nature. 2016 Nov 10;539(7628):309-313
pubmed: 27806376
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Nat Genet. 2017 Nov;49(11):1567-1575
pubmed: 28991255
Cell Rep. 2019 Mar 19;26(12):3203-3211.e5
pubmed: 30893594
Cancer Cell. 2018 Jan 8;33(1):152
pubmed: 29316430
J Exp Clin Cancer Res. 2018 Aug 16;37(1):194
pubmed: 30115078
Cell Rep. 2018 Apr 24;23(4):1220-1229
pubmed: 29694897
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Clin Cancer Res. 2019 Feb 15;25(4):1261-1271
pubmed: 30397180
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Genome Med. 2018 Jul 24;10(1):57
pubmed: 30041684
Genes Dev. 2013 Aug 15;27(16):1769-86
pubmed: 23964093
Cell Stem Cell. 2009 Nov 6;5(5):504-14
pubmed: 19896441
Genes Dev. 2015 Jun 15;29(12):1203-17
pubmed: 26109046

Auteurs

Allison R Pine (AR)

Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.
Tri-Institutional Program in Computational Biology and Medicine, New York, New York.

Stefano M Cirigliano (SM)

Department of Neurology, Weill Cornell Medicine, New York, New York.

James G Nicholson (JG)

Department of Neurology, Weill Cornell Medicine, New York, New York.

Yang Hu (Y)

Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.

Amanda Linkous (A)

Department of Neurology, Weill Cornell Medicine, New York, New York.

Ken Miyaguchi (K)

Department of Neurology, Weill Cornell Medicine, New York, New York.

Lincoln Edwards (L)

Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York.

Richa Singhania (R)

Department of Neurology, Weill Cornell Medicine, New York, New York.

Theodore H Schwartz (TH)

Department of Neurological Surgery, Weill Cornell Medicine, New York, New York.

Rohan Ramakrishna (R)

Department of Neurological Surgery, Weill Cornell Medicine, New York, New York.

David J Pisapia (DJ)

Department of Pathology, Weill Cornell Medicine, New York, New York.

Matija Snuderl (M)

Department of Pathology, NYU Langone Medical Center, New York, New York.

Olivier Elemento (O)

Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York. haf9016@med.cornell.edu ole2001@med.cornell.edu.

Howard A Fine (HA)

Department of Neurology, Weill Cornell Medicine, New York, New York. haf9016@med.cornell.edu ole2001@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH